Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT studyGerardo Rosati, Domenico Bilancia, Antonio Avallone et al.|Journal of Geriatric Oncology|2021Cited by 5